Swiss biotech company
Tolremo has raised €8.0M across 1 funding round from 2 investors, most recently a Series A round in Sep 2018. Based in Zurich, Switzerland; founded 2017; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2018-09-24 | Series A | €8.0M |
| as well as existing shareholders Zürcher Kantonalbank,BioMedPartners with participation from Redalpine and Altos Venture |
| View deal → |
